KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Nektar Therapeutics (NKTR) Return on Assets (2016 - 2025)

Historic Return on Assets for Nektar Therapeutics (NKTR) over the last 15 years, with Q3 2025 value amounting to 0.45%.

  • Nektar Therapeutics' Return on Assets rose 700.0% to 0.45% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.45%, marking a year-over-year increase of 700.0%. This contributed to the annual value of 0.34% for FY2024, which is 1600.0% up from last year.
  • Per Nektar Therapeutics' latest filing, its Return on Assets stood at 0.45% for Q3 2025, which was up 700.0% from 0.5% recorded in Q2 2025.
  • Nektar Therapeutics' 5-year Return on Assets high stood at 0.29% for Q1 2021, and its period low was 0.66% during Q1 2023.
  • In the last 5 years, Nektar Therapeutics' Return on Assets had a median value of 0.48% in 2024 and averaged 0.49%.
  • As far as peak fluctuations go, Nektar Therapeutics' Return on Assets plummeted by -2200bps in 2022, and later soared by 2700bps in 2024.
  • Nektar Therapeutics' Return on Assets (Quarter) stood at 0.44% in 2021, then decreased by -15bps to 0.5% in 2022, then crashed by -31bps to 0.66% in 2023, then soared by 41bps to 0.39% in 2024, then decreased by -15bps to 0.45% in 2025.
  • Its last three reported values are 0.45% in Q3 2025, 0.5% for Q2 2025, and 0.46% during Q1 2025.